These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3383125)

  • 1. Factors of prognostic importance in childhood non-Hodgkin's lymphoma treated with two modified LSA2-L2 protocols. A multivariate analysis approach.
    de Andrea ML; de Camargo B; Correa Alves A; Machado JC; Franco EL
    Cancer; 1988 Jul; 62(2):240-50. PubMed ID: 3383125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphoblastic lymphoma in children--a randomized trial comparing LSA2-L2 with the A-COP+ therapeutic regimen: a Pediatric Oncology Group Study.
    Hvizdala EV; Berard C; Callihan T; Falletta J; Sabio H; Shuster JJ; Sullivan M; Wharam MD
    J Clin Oncol; 1988 Jan; 6(1):26-33. PubMed ID: 3275750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Results of modified LSA2-L2 protocol with moderate-dose MTX therapy in children with untreated non-Hodgkin's lymphoma].
    Shimamoto Y; Imai S; Endo N
    Gan To Kagaku Ryoho; 1992 Mar; 19(3):395-8. PubMed ID: 1543367
    [No Abstract]   [Full Text] [Related]  

  • 4. [non-Hodgkin's lymphoma treated with modified LSA2-L2 protocol--a clinical experience and case report].
    Chiou SS; Chang TT; Perng JJ; Chen TS
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1987 Jun; 3(6):419-24. PubMed ID: 3483004
    [No Abstract]   [Full Text] [Related]  

  • 5. [Non-Hodgkinś lymphoma in childhood, preliminary results of the LSA2 L2 protocol modified by high-dose methotrexate].
    Prats Viñas J; Gallego Melcón S; Pérez Payarols J; Macía Martí J; Sánchez de Toledo J
    An Esp Pediatr; 1987 Jan; 26(1):15-21. PubMed ID: 3826937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Childhood non-Hodgkin's lymphoma and "leukemia-lymphoma syndrome": long-term results with the modified LSA2-L2 protocol.
    Vecchi V; Serra L; Pession A; Rosito P; Paolucci P; Burnelli R; Vivarelli F; Mancini AF; Paolucci G
    Pediatr Hematol Oncol; 1986; 3(3):217-28. PubMed ID: 3153234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric Oncology Group experience with modified LSA2-L2 therapy in 107 children with non-Hodgkin's lymphoma (Burkitt's lymphoma excluded).
    Sullivan MP; Boyett J; Pullen J; Crist W; Doering EJ; Trueworthy R; Hvizdala E; Ruymann F; Steuber CP
    Cancer; 1985 Jan; 55(2):323-36. PubMed ID: 3880656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified LSA2-L2 treatment in 53 children with E-rosette-positive T-cell leukemia: results and prognostic factors (a Pediatric Oncology Group Study).
    Pullen DJ; Sullivan MP; Falletta JM; Boyett JM; Humphrey GB; Starling KA; Land VJ; Dyment PG; Vats T; Duncan MH
    Blood; 1982 Nov; 60(5):1159-68. PubMed ID: 6982085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment of localized non-Hodgkin's lymphoma in children: a report from the Children's Cancer Study Group.
    Jenkin RD; Anderson JR; Chilcote RR; Coccia PF; Exelby PR; Kersey JH; Kushner JH; Meadows AT; Siegel SE; Sposto R
    J Clin Oncol; 1984 Feb; 2(2):88-97. PubMed ID: 6366148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LSA2-L2 protocol treatment of stage IV non-Hodgkin's lymphoma in children with partial and extensive bone marrow involvement.
    Duque-Hammershaimb L; Wollner N; Miller DR
    Cancer; 1983 Jul; 52(1):39-43. PubMed ID: 6573941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective therapy for poor-prognosis non-Hodgkin's lymphoma with 8 weeks of high-dose-intensity combination chemotherapy.
    Waits TM; Greco FA; Greer JP; Johnson DH; Wolff SN; Stein RS; McMaster ML; Hainsworth JD
    J Clin Oncol; 1993 May; 11(5):943-9. PubMed ID: 7683712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten years' experience with LSA2-L2 therapy for childhood advanced lymphoblastic lymphoma.
    Katz JA; Hvizdala E; Shuster J; Falletta JM; Schwenn M; Murphy SB
    J Clin Oncol; 1993 Oct; 11(10):2054-5. PubMed ID: 8410135
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.
    Fisher RI; Gaynor ER; Dahlberg S; Oken MM; Grogan TM; Mize EM; Glick JH; Coltman CA; Miller TP
    N Engl J Med; 1993 Apr; 328(14):1002-6. PubMed ID: 7680764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of acute lymphoblastic leukemia in children: modified LSA2-L2 therapy].
    Ishii E; Hara T; Ueda K; Kishida K; Nakamura E; Miyazaki S; Yoshida N
    Rinsho Ketsueki; 1985 Apr; 26(4):487-93. PubMed ID: 3862888
    [No Abstract]   [Full Text] [Related]  

  • 16. MACOP-B versus ProMACE-MOPP in the treatment of advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group.
    Sertoli MR; Santini G; Chisesi T; Congiu AM; Rubagotti A; Contu A; Salvagno L; Coser P; Porcellini A; Vespignani M
    J Clin Oncol; 1994 Jul; 12(7):1366-74. PubMed ID: 7517442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Advanced abdominal non-Hodgkin's lymphoma in the child. Features and response to treatment].
    Lobo-Sanahuja F; García I; Vargas G; Barrantes J; Jiménez E; Jiménez R
    Sangre (Barc); 1988 Jun; 33(3):196-201. PubMed ID: 3175816
    [No Abstract]   [Full Text] [Related]  

  • 18. Childhood non-Hodgkin's lymphoma. The results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2).
    Anderson JR; Wilson JF; Jenkin DT; Meadows AT; Kersey J; Chilcote RR; Coccia P; Exelby P; Kushner J; Siegel S; Hammond D
    N Engl J Med; 1983 Mar; 308(10):559-65. PubMed ID: 6338381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: the 30-year experience at Memorial-Sloan-Kettering Cancer Center.
    Mora J; Filippa DA; Qin J; Wollner N
    Cancer; 2003 Sep; 98(6):1283-91. PubMed ID: 12973853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new treatment protocol for childhood non-Hodgkin's lymphoma: preliminary evaluation.
    de Andrea ML; de Camargo B; Melaragno R
    J Clin Oncol; 1990 Apr; 8(4):666-71. PubMed ID: 2179479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.